Personal stories

Drawing on his fascination with airplane technology, Thorsten Siess, Ph.D., came up with an idea that became the Impella heart pump. Now, 26 years since it entered the market, this groundbreaking device has helped more than 450,000 patients recover from heart injuries.

The first-of-its-kind targeted oral peptide therapy for moderate to severe plaque psoriasis has been chosen for the annual list, which recognizes innovations for their originality, ambition and impact.

Check out this infographic breakdown of the company’s third-quarter performance, with highlights from its Innovative Medicine and MedTech businesses.

Built to expand OR capacity, maintain procedural momentum and elevate performance, OTTAVA™ is opening new possibilities in surgery. Neda Cvijetic, Global Head of Robotics & Digital R&D, MedTech at Johnson & Johnson, explains what surgeons need to know.

A new type of medication is tackling a problem that has long frustrated drug developers: how to deliver peptide therapies orally and hit their target more precisely.

Johnson & Johnson’s Leonardo Diaz, M.D., addresses common misconceptions about schizophrenia, the critical importance of preventing relapse and why there’s so much optimism about treatments.

Transforming cancer patients’ own cells into a targeted treatment is a complex and nuanced process. Jessica Torfs, director of Global CAR-T Supply Chain at Johnson & Johnson, explains what it takes to deliver this cutting-edge personalized therapy.

Through collaborations with Americares, Heart to Heart International, the American Red Cross, International Medical Corps and Sigma Theta Tau International Honor Society of Nursing, Johnson & Johnson, with support from the J&J Foundation, is standing with those who care for communities when catastrophe occurs.

Warm autoimmune hemolytic anemia is a rare, life-threatening disease that causes intense fatigue. Johnson & Johnson has a new therapy that targets the underlying drivers of the disease. Here, two patients—and Johnson & Johnson employees—share their journey, from symptoms and diagnosis to managing work and personal life.

This disease is highly treatable if caught early—but in its earliest stages, prostate cancer often has no symptoms, allowing it to develop without detection. Learn more about this common cancer and how Johnson & Johnson is innovating across both early-stage and advanced disease.